388 related articles for article (PubMed ID: 29781349)
1. Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.
Smith E; Zhou W; Shindiapina P; Sif S; Li C; Baiocchi RA
Expert Opin Ther Targets; 2018 Jun; 22(6):527-545. PubMed ID: 29781349
[TBL] [Abstract][Full Text] [Related]
2. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H; Qian K; Ho MC; Zheng YG
Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
[TBL] [Abstract][Full Text] [Related]
4. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
Al-Hamashi AA; Diaz K; Huang R
Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
[TBL] [Abstract][Full Text] [Related]
5. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
6. Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level.
Tewary SK; Zheng YG; Ho MC
Cell Mol Life Sci; 2019 Aug; 76(15):2917-2932. PubMed ID: 31123777
[TBL] [Abstract][Full Text] [Related]
7. Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*.
Sutherland M; Li A; Kaghad A; Panagopoulos D; Li F; Szewczyk M; Smil D; Scholten C; Bouché L; Stellfeld T; Arrowsmith CH; Barsyte D; Vedadi M; Hartung IV; Steuber H; Britton R; Santhakumar V
ChemMedChem; 2021 Apr; 16(7):1116-1125. PubMed ID: 33513288
[TBL] [Abstract][Full Text] [Related]
8. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
[TBL] [Abstract][Full Text] [Related]
10. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery.
Wang Y; Hu W; Yuan Y
J Med Chem; 2018 Nov; 61(21):9429-9441. PubMed ID: 29870258
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites.
van Haren M; van Ufford LQ; Moret EE; Martin NI
Org Biomol Chem; 2015 Jan; 13(2):549-60. PubMed ID: 25380215
[TBL] [Abstract][Full Text] [Related]
14. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms.
Chen Y; Shao X; Zhao X; Ji Y; Liu X; Li P; Zhang M; Wang Q
Biomed Pharmacother; 2021 Dec; 144():112252. PubMed ID: 34619493
[TBL] [Abstract][Full Text] [Related]
15. An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022).
Dong J; Duan J; Hui Z; Garrido C; Deng Z; Xie T; Ye XY
Expert Opin Ther Pat; 2022 Dec; 32(12):1185-1205. PubMed ID: 36594709
[TBL] [Abstract][Full Text] [Related]
16. Targeting protein arginine methyltransferase 5 in disease.
Richters A
Future Med Chem; 2017 Nov; 9(17):2081-2098. PubMed ID: 29076773
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine methyltransferases: promising targets for cancer therapy.
Hwang JW; Cho Y; Bae GU; Kim SN; Kim YK
Exp Mol Med; 2021 May; 53(5):788-808. PubMed ID: 34006904
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
Dominici C; Sgarioto N; Yu Z; Sesma-Sanz L; Masson JY; Richard S; Raynal NJ
Clin Epigenetics; 2021 Mar; 13(1):54. PubMed ID: 33691794
[TBL] [Abstract][Full Text] [Related]
20. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).
Obianyo O; Thompson PR
J Biol Chem; 2012 Feb; 287(8):6062-71. PubMed ID: 22219200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
